Managing heart and lung symptoms after COVID-19
Part of Infections, Lungs & breathing clinical trials.
This trial tests a program to help people with ongoing fatigue, shortness of breath, or chest pain after COVID-19. It uses a personalized plan to improve your daily function and heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older
- You have had COVID-19 and still have symptoms like tiredness, shortness of breath, or chest pain
- You are eligible for Medicare (Australia)
- You can walk and do light exercise without help
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with lingering post-COVID symptoms, especially breathing and lung-related findings, using home monitoring and medical tests. It may help researchers understand what’s driving ongoing symptoms and identify patterns that could guide better care.
This study tests a program to help reduce fatigue and other symptoms in people with Long COVID. It involves using an internet-connected device to access the program remotely.
This trial tests a breathing exercise called resonance breathing training to help people with long COVID who have damage to their heart muscle. The goal is to see if this simple, drug-free technique can improve heart function and reduce symptoms.
This trial tests a mind-body intervention to help people with ongoing long COVID symptoms like pain, fatigue, or brain fog. If you've had COVID-19 and have had symptoms at least 3 days a week for 3 months, this study might help.
This study tests whether a personalized exercise program can help reduce fatigue after a COVID-19 infection. You'll work with a coach over video calls to see if gentle activity can improve your energy levels.
This trial tests a natural compound to see if it can reduce ongoing inflammation and symptoms like fatigue, brain fog, or shortness of breath that linger after a COVID-19 infection. It's for people who still have symptoms at least 2 months after getting sick.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.